We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UBS Group AG to Boost Majority Stake to 51% in China JV
Read MoreHide Full Article
The Swiss bank — UBS Group AG (UBS - Free Report) — has expressed interest in increasing majority stake in its Chinese securities venture with the submission of application to China’s securities regulator — The China Securities Regulatory Commission (CSRC), Bloomberg reported. This moves follows CSRC’s lessening restrictions on foreign ownership of brokerages announced earlier this year.
Notably, indicating their readiness to allow greater access to global banks into their financial markets, the securities regulator has set the month of June as deadline for foreign companies to increase majority stake to 51% in securities JVs, up from the existing ceiling of 49%. Regarding this, the CSRC detailed the guidelines and experience mandatory for foreign shareholders, last week, along with the scale of businesses which can be recognized.
Therefore, to explore opportunities for its investment banking, wealth and asset management operations in China, this Zurich-based bank targets to raise stake to 51%, up from the existing 24.99%.
Conclusion
Global investment banks’ expansion has been limited in China for the past few years due to restrictions imposed on ownerships. Therefore, with the easing out of boundaries for global banks and the growing Chinese economy, major foreign banks will be attracted to expand here. Apart from UBS Group AG, Morgan Stanley (MS - Free Report) and Goldman Sachs (GS - Free Report) are among the major brokerages likely to acquire majority stakes in their Chinese joint ventures.
Over the last six months, shares of UBS Group AG have decreased 3.1% compared with the 1.1% decline registered by the industry.
Currently, UBS Group AG carries a Zacks Rank #5 (Strong Sell).
A better-performing foreign bank includes Lloyds Banking Group PLC (LYG - Free Report) , with a Zacks Rank #1. The bank has been witnessing slight upward estimate revisions for the last 90 days.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
UBS Group AG to Boost Majority Stake to 51% in China JV
The Swiss bank — UBS Group AG (UBS - Free Report) — has expressed interest in increasing majority stake in its Chinese securities venture with the submission of application to China’s securities regulator — The China Securities Regulatory Commission (CSRC), Bloomberg reported. This moves follows CSRC’s lessening restrictions on foreign ownership of brokerages announced earlier this year.
Notably, indicating their readiness to allow greater access to global banks into their financial markets, the securities regulator has set the month of June as deadline for foreign companies to increase majority stake to 51% in securities JVs, up from the existing ceiling of 49%. Regarding this, the CSRC detailed the guidelines and experience mandatory for foreign shareholders, last week, along with the scale of businesses which can be recognized.
Therefore, to explore opportunities for its investment banking, wealth and asset management operations in China, this Zurich-based bank targets to raise stake to 51%, up from the existing 24.99%.
Conclusion
Global investment banks’ expansion has been limited in China for the past few years due to restrictions imposed on ownerships. Therefore, with the easing out of boundaries for global banks and the growing Chinese economy, major foreign banks will be attracted to expand here. Apart from UBS Group AG, Morgan Stanley (MS - Free Report) and Goldman Sachs (GS - Free Report) are among the major brokerages likely to acquire majority stakes in their Chinese joint ventures.
Over the last six months, shares of UBS Group AG have decreased 3.1% compared with the 1.1% decline registered by the industry.
Currently, UBS Group AG carries a Zacks Rank #5 (Strong Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A better-performing foreign bank includes Lloyds Banking Group PLC (LYG - Free Report) , with a Zacks Rank #1. The bank has been witnessing slight upward estimate revisions for the last 90 days.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>